Recent Headlines
Within Health Care Products
PolyGel LLC Welcomes Two Dynamic Leaders to Its Team
PolyGel LLC, a leading innovator in gel wellness products, is proud to announce the addition of two highly experienced professionals, Carrie Kovacs and Anna Hibschman Ferguson, to its team. Their extensive expertise and proven track records will undoubtedly bolster PolyGel's efforts in sales and... - May 04, 2024 - PolyGel LLC
Caresmartz Exhibits Innovative Home Care Technology at PHA 2024
Caresmartz, a leading homecare solutions provider, will be exhibiting its CareSmartz360 home care software at the PHA 2024 Annual Conference from May 15-17 at the Kalahari Resorts, the Poconos. Attendees at the conference are invited to visit CareSmartz360 at Booth #60 for live product demonstrations, discussions about their specific needs, and networking opportunities - May 03, 2024 - Caresmartz, Inc.
GUIDE Announces Groundbreaking Partnership with Q.S.C. Enterprises to Empower Employees at McDonald's
GUIDE, the pioneering developer of The GUIDE App, a resilience and wellness app delivering industry-leading results in mental, emotional, and physical well-being, is thrilled to announce a significant new partnership with Q.S.C. Enterprises, a McDonald's franchise group in Northeast Pennsylvania. - May 02, 2024 - GUIDE
Pagari Life Science Corp. Announces the Commercial Launch of Helocaine®, a New Transformative Cold Sore Treatment
Pagari Life Science Corporation is revolutionizing cold sore treatment with the commercial launch of Helocaine®. - May 01, 2024 - Pagari Life Sciences
Revolutionizing Clinical Trials: AnzuBridge Unveils Next-Generation Solutions for Improved Efficacy Evaluations in the Treatment of Rare Disease
AnzuBridge® updates its CDMS to enhance biotech evaluations with advanced video tools, ensuring precise efficacy recording and compliance. It supports scalable trials and features HIPAA-compliant media capture, ePRO for patient engagement, and sophisticated video review capabilities, all integrated with a Learning Management System for efficient trial management. - April 30, 2024 - Anzu
No More Acetone: Thar Process Develops Clean and Green Process to Create Sterile, Fat-Free Lecithin Powder and GMP Quality Oils for Human Consumption
Thar Process, with 34 years of expertise in supercritical fluid extraction, has developed a sustainable way to produce de-fatted lecithin powder that has less oil and longer shelf-life stability. The new process is semi-continuous and sustainable because it utilizes upcycled CO2 from waste sources instead of using toxic acetone which is the industry standard. - April 26, 2024 - Thar Process, LLC
Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings
Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union. This... - April 25, 2024 - ALPCO
Flexxbotics Announces Robot Compatibility with Heidenhain CNC Controls
Flexxbotics, delivering workcell digitalization for robot-driven manufacturing, today announced advanced robot machine tending connectivity compatible with the entire range of Heidenhain CNC controllers. With Flexxbotics next generation machining environments using robotics with Heidenhain... - April 25, 2024 - Flexxbotics
Mirror Biologics, Inc. Appoints Elizabeth Czerepak as Chief Financial Officer and VP Corporate Development
Mirror Biologics, Inc., a clinical stage biopharmaceutical company announces the appointment of Elizabeth Adkins Czerepak as Chief Financial Officer (CFO) and Vice President of Corporate Development effective April 15, 2024. Ms. Czerepak has served as CFO of several biotechnology companies over... - April 18, 2024 - Mirror Biologics, Inc.
SilverPlug USA, Helping to Reduce Dental Implant Failures for Patients
Developed in Switzerland, SilverPlug contains Silver Zeolyte, a natural antibacterial that prevents the formation of biofilm and bacteria. Micro-movement of the implant abutment allows diverse bacteria to form inside the implant tunnel different from that of periodontal disease. The clinician and patient will notice no smell when performing implant maintenance, the lack of mucositis and periimplantitis over the life of the implant. 10 years of clinical proof for claims. - April 12, 2024 - SilverPlug
PureShowers.co.uk Launches Groundbreaking Website Redesign to Elevate Shopping Experience
PureShowers.co.uk, a leader in innovative shower filter technology, is excited to announce the launch of its significantly upgraded website. This major overhaul, the first in eight years, enhances the online shopping experience for customers seeking healthier shower solutions. The new website features a faster, more modern design that is optimized for mobile devices, making it easier than ever for consumers to access and purchase high-quality shower filters. - April 12, 2024 - PureShowers.co.uk
I Holland Unveils TSAR 2: Advancing Predictive Modelling in Tablet Compression
I Holland proudly announces the development of TSAR 2, an advanced predictive model developed through a collaborative partnership between academia and industry. Building upon the success of the Tabletting Science Anti-Stick Research (TSAR) project, I Holland continues its groundbreaking research... - April 12, 2024 - I Holland Ltd.
Boiron’s New Arnicare® Wellness Kits Offer Holistic Approach to Pain Management
Boiron, world leader in homeopathic medicines, introduces its new Arnicare Wellness Kits as convenient and comprehensive solutions for painsleep and stress relief. The kits are designed to provide individuals with daytime and nighttime options to manage pain with occasional sleeplessness and... - April 11, 2024 - Boiron
Huntington Study Group Launches Project AWARE 2.0 Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce the launch of Project AWARE 2.0, an observational study developed in collaboration with Roche Products Limited and Genentech to understand and improve Awareness, Willingness, and... - April 10, 2024 - Huntington Study Group
Minus K Congratulates to the Winners of Their 2023/2024 Educational Giveaway
Minus K congratulates the four winners of the Minus K's 2023/2024 Educational Giveaway. Over $75,000 of new passive mechanical hub hertz vibration isolators have been granted to universities and colleges in the U.S. over the last ten years. - April 10, 2024 - Minus K Technology Inc.
FuseBio Presents New Data at AACR: Targeting a Functionally-Selective IL-18 (F-18) to PD-1: A Next Generation Checkpoint Inhibitor with Enhanced Anti-Tumor Activity
FuseBio's unique attenuation mechanism renders IL-18, a functionally selective IL-18, resistant to IL-18BP and 1 million percent less active in circulation and yet still retain nearly full activity when targeted to PD-1+/IL-18R+ cells, the key functional immune cells in tumors. It is designed to retain full activity of PD-1 checkpoint blockade and simultaneously deliver a functionally selective IL-18 (F-18) to preserve and enhance the anti-tumor activity of immune cells. - April 09, 2024 - Fuse Biotherapeutics
Renowned Advocate Lorrinda Gray-Davis to Speak at TRIO's Remember & Rejoice Event
As a guest speaker, Lorrinda Gray-Davis will share her personal journey of hope, resilience, and gratitude, highlighting the profound impact of organ donation on individuals, families, and communities. "Remember & Rejoice" stands as the single largest gathering of donor families and transplant recipients in the country, providing a sacred space for reflection, remembrance, and rejoicing. - April 06, 2024 - TRIO-Oklahoma
CareSmartz360 Unveils Facility Management Solution for Home Care to Streamline Staffing
CareSmartz360 has launched its easy-to-navigate Facility Staffing solution, which offers the core benefits of caregiver management, scheduling that maximizes caregiver utilization, and a document verification process that helps ensure compliance. All of these significantly help improve operational efficiency, care quality, and thus, client satisfaction. - April 03, 2024 - Caresmartz, Inc.
Flexxbotics Delivers Robot Compatibility with Brother CNC Machines
Flexxbotics delivering workcell digitalization for robot-driven manufacturing, today announced advanced robot machine tending connectivity compatible with the complete line of Brother CNC machines. With Flexxbotics next generation machining environments using robotics with Brother equipment achieve... - March 28, 2024 - Flexxbotics
Navigating LIMS Data Migration: Ensuring Seamless Transition and Lab Data Integrity
Register for the webinar to gain insights into the challenges of LIMS data migration, as well as the approaches and best practices to ensure a seamless transition and maintain lab data integrity. - March 23, 2024 - CloudLIMS
Ngram Expands AI Dataset Offerings with Descriptive Question Answering for Healthcare
New open-source medchat-qa-descriptive dataset enables AI models to provide comprehensive answers to complex medical queries. - March 22, 2024 - ngram Inc.
Parvus Announces Collaboration with AbbVie to Develop IBD Therapies Based on the Parvus Navacim Platform Technology
The collaboration will combine AbbVie’s expertise in Immunology with Parvus’ innovative Navacim™ regulatory T cells (Treg) immune tolerization platform technology to develop therapies for Inflammatory Bowel Disease Parvus Therapeutics announced today that it has entered into an... - March 20, 2024 - Parvus Therapeutics U.S., Inc.
AMD Stopper, a New Treatment for Age-Related Macular Degeneration, Seeks Partnerships with Manufacturers in the Healthcare Industry
California inventor of oral treatment for Age-Related Macular Degeneration, a common eye disease which affects tens of millions globally, is working tirelessly to bring his formulation to market. - March 20, 2024 - AMD Stopper
Foam Swab Manufacturer Super Brush LLC Will be Exhibiting at the 2024 FORUM LABO Lyon
US-based Super Brush LLC is pleased to announce that they will be exhibiting at this year's FORUM LABO Lyon to be held March 27-28, 2024, in Lyon France, at the Lyon Convention Centre. FORUM LABO is the showcase of the laboratory supplier sector where solutions, innovations, sharing of experiences,... - March 20, 2024 - Super Brush LLC
Brooke Chase Associates, Inc. Selected for Inclusion in Hunt Scanlon’s 2024 Select Guide to America’s Top 250 Executive Search Firms
Brooke Chase Associates, Inc. Chairman and CEO, Joseph McElmeel, is pleased to announce that Hunt Scanlon Media, the most widely referenced, single source for information in the human capital sector, has selected Brooke Chase Associates, Inc. for inclusion in Hunt Scanlon’s 2024 Select Guide to America’s Top 250 Executive Search Firms. - March 16, 2024 - Brooke Chase Associates, Inc.
ACL Digital and PhoenixAI.tech Partner to Take AI-Driven Drone Technology to New Heights
The strategic partnership enhances ACL Digital’s capabilities with PhoenixAI.tech, focusing on AI drone solutions for UAVs, IoT, and edge computing to revolutionize operations significantly Beyond Visual Line of Sight (BVLOS) missions. - March 16, 2024 - ACL Digital
Eminent Spine's 3D Titanium Anterior Lumbar Stand-Alone System Usage Report and Clinical Study
Eminent Spine's 3D Titanium ALIF Stand-Alone System received FDA 510(K) clearance in October 2022 and has reported 102 total implants and 273 screws used in operations. - March 14, 2024 - Eminent Spine
Telegenisys Announces MedLawXpress Program for Attorneys for Rapid Medical Assessment
Telegenisys Announced MedLawXpress program for personal injury and malpractice law firms for rapid medical case assessments and record review. - March 14, 2024 - Telegenisys Inc.
Biomed Industries Announces Triple IGF-1/GLP-1/GIP Receptor Agonist NA-931 for Obesity
A new drug for obesity that is both safe and effective. - March 13, 2024 - Biomed Industries Inc.
iView Therapeutics Inc. Announced FDA’s Clearance of IND Application for IVW-1001 Ophthalmic Eyelid Wipe to Treat Signs and Symptoms of Dry Eye Disease
iView Therapeutics Inc., a clinical stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, announces that the U.S. Food and Drug Administration (FDA) cleared iView’s Investigational New Drug (IND) application to for the initiation of a Phase 1/2 clinical... - March 11, 2024 - iView Therapeutics Inc.
mpathic Welcomes Dr. Danielle Schlosser as Chief Innovation Officer and Co-Founder
Dr. Danielle Schlosser joins mpathic as Chief Innovation Officer and Co-Founder, poised to advance AI in healthcare and life sciences. Bringing vast expertise, she'll drive innovation and growth, enhancing conversational analytics to improve patient care. Her strategic role underpins mpathic’s leadership in tech-integrated healthcare solutions. - March 11, 2024 - mpathic
Defined Bioscience Introduces Ready-CEPT™: A New Cell Viability Enhancer
Defined Bioscience is pleased to announce the launch of Ready-CEPT™ 1000X, a new product designed to improve stem cell survival, growth, and health during critical processes such as routine passaging, cryopreservation, and freeze-thaw recovery. - March 11, 2024 - Defined Bioscience Inc.
Utech Products Inc. Achieves ISO 9001
Utech Products Inc. Achieves ISO 9001 Certification (Certification Registration No. 961 24 5889), Demonstrating Commitment to Quality and Customer Satisfaction. - March 09, 2024 - Utech Products Inc.
Flexxbotics Provides Robot Compatibility with DMG MORI CNC Machines and Equipment
Flexxbotics, delivering workcell digitalization for robot-driven manufacturing, today announced advanced robot machine tending connectivity compatible with the entire range of DMG MORI machine tools including turning, milling, ultrasonic, lasertec, additive manufacturing, and grinding. With... - March 07, 2024 - Flexxbotics
Biomed Industries to Present Groundbreaking Research at AD/PD™ 2024 International Conference
Biomed Industries, Inc. (Biomed), a leading bio-pharmaceutical company, is set to present three significant papers at the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases, taking place in Lisbon, Portugal, from March 5 to 9. The presentations by Biomed... - March 06, 2024 - Biomed Industries Inc.
Flexxbotics Appoints Former Senior Vice President of Aras, Marc Lind, as Chief Strategy Officer and Chief Marketing Officer
Flexxbotics, delivering workcell digitalization for robot-driven manufacturing, today announced the appointment of accomplished manufacturing software executive, Marc Lind, as Chief Strategy Officer (CSO) and Chief Marketing Officer (CMO). The addition strengthens Flexxbotics’ leadership in... - March 04, 2024 - Flexxbotics
Canopy Launches Its New Online Portal
Canopy, a leader in total workplace behavioral health announced the launch of its new online portal, a groundbreaking platform that gives members the option to search and self-refer to licensed mental health therapists. This enhancement underscores Canopy's commitment to transforming Employee... - March 03, 2024 - Canopy
IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024
IVIEW Therapeutics Inc. announces to present the positive topline result in the Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis in the upcoming 2024 ARVO (The Association for Research in Vision and Ophthalmology) national meeting in Seattle, WA. The Presentation... - February 28, 2024 - iView Therapeutics Inc.
Ideal Male Labs’ Physician Ari Magill, MD Announces Landmark Opening of Its New Manufacturing Facility in Missouri
Ideal Male’s men's health specialist Dr. Ari Magill announced today the opening of a new dietary supplement production facility in Fenton, Missouri. This American-made facility will focus on creating premium supplements to support men's health and wellbeing. "I'm thrilled to open this... - February 23, 2024 - Ideal Male Labs LLC
Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies
Cayman Chemical introduces the latest addition to the company’s portfolio of lipid nanoparticle (LNP) research tools for academic, pharma, and biotech researchers worldwide. The LipidLaunch™ product line helps researchers pursue LNPs for the delivery of nucleic acid therapies in untold health applications, ranging from vaccine development to cancer and cell or gene therapies. - February 22, 2024 - Cayman Chemical Company
innoviHealth® Acquires MedAbbrev.com®, the Premier Reference Tool for Medical Acronyms and Abbreviations
Recent Deal Further Expands innoviHealth’s Trusted Suite of Medical Technology Software and Services MedAbbrev is Available as a Stand-alone Product, Embedded in innoviHealth’s HCC Coder Pro and also in the Find-A-Code Solution - February 21, 2024 - innoviHealth
Brooke Chase Associates, Inc. Recruits Sonya Shoemaker as Regional Sales Manager Southeast for CNC Cabinetry
Joseph McElmeel, Chairman and CEO of executive search firm Brooke Chase Associates, Inc. is pleased to announce the successful recruitment by its Executive Recruiter, Ben Durshimer, of Sonya Shoemaker as Regional Sales Manager Southeast for CNC Cabinetry. Jennifer Young, Vice President of Sales and Marketing, is excited to welcome Sonya as a key member of the regional leadership team. - February 21, 2024 - Brooke Chase Associates, Inc.
Antiquesmart - The New Way of Buying Old Things
Local Group Creates Unique App for The Antique Community A local group comprised of individuals from the Kenosha area has joined forces with Zetaton, a Milwaukee-based leading technology development company, to unveil a groundbreaking solution tailored to the antique community. Introducing... - February 19, 2024 - Zetaton
Gotham Biotech’s Histoplasma Urinary Antigen EIA Kit Now Available for Purchase as Histoplasma Spreads in the U.S.
Histoplasmosis is a systemic disease caused by the thermally dimorphic fungus Histoplasma capsulatum. H. capsulatum is distributed worldwide and endemic to the Ohio and Mississippi River Valleys, where the CDC estimates 60% to 90% of people who live in the region have been exposed to the fungus at some point during their life, and to certain regions of Central and South America. Medicare records from 2007 to 2016 have found cases of histoplasmosis have now spread to 47 states and Washington, DC. - February 15, 2024 - Gotham Biotech
GENINVO, a Leading Provider of Life Science Product and Business Solutions Announced the Offering of Its On-Demand Service/Tool: ApoGI™
ApoGI™ is an integrated, one stop automation platform that leverages Artificial Intelligence and Machine Learning algorithms to focus on standards and metadata driven generation of artifacts. The Primary objective of this platform is to help SMEs (Subject matter experts) focus on curating... - February 15, 2024 - GenInvo, Inc.
Flexxbotics Named Winner of Hexagon Sixth Sense Next Gen Manufacturing Technology Competition
Flexxbotics, delivering workcell digitalization for robot-driven manufacturing, has been named a winner of Hexagon’s Manufacturing Intelligence Division’s Sixth Sense Program for Flexxbotics’ cutting-edge solution that delivers robot-driven manufacturing with autonomous process... - February 15, 2024 - Flexxbotics
NAD3® Supplement Study: Memphis Health Sciences College Discovers Key to Cellular Rejuvenation
In a groundbreaking development, the College of Health Sciences at the University of Memphis, spearheaded by leading researchers Janine Hellenbrand, Richard J. Bloomer, and Marie Van der Merwe, has revealed the remarkable effects of NAD3® supplementation on adult stem cell circulation in... - February 14, 2024 - High Performance Nutrition
Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report
Sponsor Outsourcing Dollars May Shift to Clinical Site Networks, Transforming the CRO Relationship - February 13, 2024 - Life Science Strategy Group, LLC
Microvascular Therapeutics Welcomes Thom Tulip as Chief Business Officer
Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing the next generation of microbubbles unlocking the therapeutic potential of ultrasound, proudly announces the appointment of Dr Thom Tulip as their new Chief Business Officer. In this pivotal role, Dr Tulip will lead capital raises to propel MVT's cutting-edge technologies into the market. - February 10, 2024 - Microvascular Therapeutics, Inc.
CloudLIMS Demonstrates Advances in Its LIMS for Clinical and Analytical Labs at Pittcon 2024
CloudLIMS demonstrates advances in its secure, configurable LIMS for clinical & analytical testing labs at booth 1905 at Pittcon 2024 from February 26-28, 2024. - February 08, 2024 - CloudLIMS